1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea and Fever

1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea has been researched along with Fever* in 1 studies

Other Studies

1 other study(ies) available for 1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea and Fever

ArticleYear
Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat.
    Neuroscience, 2008, Sep-22, Volume: 156, Issue:1

    Transient receptor potential vanilloid 1 (TRPV1) receptor antagonists have gained much attention for their potential to treat inflammatory and neuropathic pain. However, systemic administration of TRPV1 antagonists induces a period of hyperthermia, a potential liability for small molecule development. Here we characterize the effects of the TRPV1 antagonist A-425619 on body temperature (T(b)) in the rat when administered: (1) alone at different times of the circadian cycle, (2) as repeated hourly or daily treatment, (3) as pre-treatment to prevent capsaicin-induced hypothermia, (4) to capsaicin-desensitized animals, and (5) prior to a heat challenge. Changes in T(b) were compared with compound exposure data, locomotor activity, and time course of efficacy in inflammatory pain models. Without affecting locomotor activity, oral administration of A-425619 induced a transient period of hyperthermia that was followed by a period of hypothermia, a profile unique among reported TRPV1 antagonists. Repeated hourly administration of A-425619 produced an increase in T(b) similar to a single administration. A-425619 had no effect on T(b) when administered to capsaicin-desensitized rats. The duration of A-425619-induced hyperthermia, but not hypothermia, was dependent on the time of the circadian cycle when administered. Pre-treatment with A-425619 attenuated capsaicin-induced hypothermia and did not potentiate T(b) or alter thermoregulatory behavioral responses during a heat challenge. These results indicate that A-425619-induced hyperthermia is transient, circadian-dependent, not related to exposure levels, locomotor activity, or time course of analgesic action, and does not affect the ability to thermoregulate during a heat challenge.

    Topics: Administration, Oral; Animals; Body Temperature; Body Temperature Regulation; Capsaicin; Circadian Rhythm; Drug Administration Schedule; Fever; Hypothalamus; Hypothermia; Isoquinolines; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors; TRPV Cation Channels; Urea

2008